The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQRT.L Regulatory News (QRT)

  • There is currently no data for QRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 Trading Update

19 Oct 2005 07:00

Quarto Group Inc19 October 2005 THE QUARTO GROUP, INC Q3 Trading Update Management's unaudited trading results for the quarter ended September 30, 2005,and for the nine- and twelve-month periods ending on the same date, excludingthe amortization of intangibles and exceptional items, against the prior periodcomparatives, and prepared under IFRS, are as follows: Q3 9 Months Trailing 12 Months 2005 2004 2005 2004 2005 2004 £000 £000 £000 £000 £000 £000 Revenue 28,397 25,657 66,595 56,706 89,639 76,433 -------- ------ ------- ------- ------- -------Gross profit 9,106 8,531 22,582 19,205 30,637 26,161Overheads (6,463) (6,097) (17,772) (14,800) (22,716) (19,054) -------- ------ ------- ------- ------- -------Operatingprofit 2,643 2,434 4,810 4,405 7,921 7,107 -------- ------ ------- ------- ------- -------EBITDA* 3,355 3,082 6,664 6,242 9,834 9,262 -------- ------ ------- ------- ------- ------- * earnings before interest, tax, depreciation and amortization, exceptionalitems, and corporate expenses not attributable to operations "The third quarter trading results leave us slightly behind where we expected tobe for the year to date but, as the trailing 12 months' operating results show,comfortably ahead overall. The principal impact has come from poor retailtrading in the UK, and it isn't clear whether this will pick up as we head intothe all-important final quarter of the year," commented Laurence F Orbach,chairman and chief executive officer of Quarto. "Fortunately, much of ourbusiness is in international co-edition publishing, where there is good forwardvisibility. It is very encouraging to report that 1001 Albums You Must HearBefore you Die, the latest title in our hugely successful 1001 series, hasreprinted in several major markets, even before going on sale. "The UK market (which accounts for approximately one-sixth of Group turnover) isparticularly difficult, and economic uncertainties persist elsewhere, but wehave sound reasons to believe that 2006 will be a solid year of growth forQuarto. The changes in our US publishing businesses that we have implementedduring this year will be bedded in; the investment we have been making inimproving their title ranges will translate into sales; the strong newco-edition lists appearing this fall will feed through into reprints andforeign-language editions; and cyclical factors will all favour us, subject, ofcourse, to currency and interest rate movements." Notes for Editors: Quarto is an international book publisher with two principal strands ofactivity: it publishes, under imprints owned by the Group, books and art printsin the US, the UK, and Australia; and it creates books that are licensed toother publishers for publication under their own imprints in many languagesaround the world. 2004 was Quarto's sixth successive year of increase in underlying EPS. Quartomade four acquisitions in the second half of 2004 and the first half of 2005: inthe USA, the UK, Australia and New Zealand. Enquiries: The Quarto Group, Inc. 020-7700 9000Laurence Orbach (Chairman & CEO)Mick Mousley (Finance Director) Bankside Consultants LimitedCharles Ponsonby 020-7367 8851 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Sep 20205:02 pmRNSDirector/PDMR Shareholding
28th Jul 20203:45 pmRNSHalf-year Report
24th Jun 20203:16 pmRNSResult of Annual Meeting
28th May 20209:50 amRNSAnnual Financial Report
23rd Apr 20207:00 amRNSFinal Results
25th Mar 20209:57 amRNSTrading Statement
25th Mar 20207:00 amRNSTrading Statement
26th Feb 20201:10 pmRNSHolding(s) in Company
10th Feb 20202:29 pmRNSDirectorate Change
6th Feb 20209:13 amRNSHolding(s) in Company
4th Feb 20207:00 amRNSDirector/PDMR Shareholding
3rd Feb 20207:00 amRNSResult of Open Offer
31st Jan 202010:35 amRNSResult of Special Meeting
28th Jan 20205:42 pmRNSStatement re: Media Speculation
16th Jan 20203:45 pmRNSPublication of Prospectus and Circular
16th Jan 20207:00 amRNSOpen Offer to raise £13.9 million
15th Jan 20206:26 pmRNSIntention to launch an Open Offer
8th Nov 20194:32 pmRNSChange of Adviser
16th Aug 20197:00 amRNSHalf-Year Results
11th Jul 20198:17 amRNSChange of Broker
1st Jul 20191:30 pmRNSAppointment of CFO
14th Jun 20195:29 pmRNSHolding(s) in Company
11th Jun 20193:42 pmRNSHolding(s) in Company
11th Jun 201911:00 amRNSHolding(s) in Company
10th Jun 20195:32 pmRNSDirector/PDMR Shareholding
16th May 20195:12 pmRNSAnnual Meeting Result
25th Apr 20194:59 pmRNSAppointment of Non-Executive Director & CFO
23rd Apr 20194:59 pmRNSAnnual Financial Report
14th Mar 20193:33 pmRNSDirector Declaration
11th Mar 20197:00 amRNSFinal Results for the Year Ended 31 December 2018
27th Feb 20192:56 pmRNSDirector Declaration
6th Dec 20181:27 pmRNSDirector/PDMR Shareholding
14th Nov 20184:01 pmRNSDirector/PDMR Shareholding
12th Nov 20187:00 amRNSDirector Declaration
1st Nov 20187:00 amRNSExtension and amendment of banking facilities
15th Oct 20183:05 pmRNSDirector Declaration
17th Sep 20187:00 amRNSHalf-year Report
15th Aug 201811:30 amRNSSpecial Meeting result
30th Jul 20188:00 amRNSNotice of Special Meeting of Shareholders
26th Jul 201811:06 amRNSBoard change
17th Jul 20183:25 pmRNSBoard appointment disclosure
12th Jul 201812:05 pmRNSBoard changes
5th Jun 201811:09 amRNSCFO Resignation & Board Change
24th May 20183:10 pmRNSCEO resignation
22nd May 201811:55 amRNSListing Rule 9.6.13R Disclosure
17th May 20185:49 pmRNSUpdate on roles of new Directors
17th May 20185:45 pmRNSChange of Control
17th May 201812:24 pmRNSAnnual Meeting statement and result
2nd May 20185:45 pmRNSHolding(s) in Company
23rd Apr 20187:00 amRNSAnnual Report and Notice of Annual Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.